Johnson & Johnson Stock Underperforms Monday When Compared To Competitors Despite Daily Gains

Johnson & Johnson

Change company Symbol lookup

Select an option...

JNJ Johnson & Johnson

BAC Bank of America Corp

CANQF CanaQuest Medical Corp

FRSHY China Jinmao Holdings Group Ltd

EQH-C Equitable Holdings Inc

IBTX Independent Bank Group Inc

DLTR Dollar Tree Inc

FRTX Fresh Tracks Therapeutics Inc

PLXS Plexus Corp

YEXT Yext Inc

Health Care : Pharmaceuticals | Large Cap Blend

Company profile

Johnson & Johnson is a diversified healthcare products company. The Company is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. It operates through three segments: Consumer Health, Pharmaceutical and MedTech. Its primary focus is products related to human health and well-being. The Consumer Health segment includes a range of products that is focused on personal healthcare used in the skin health/beauty, over-the-counter medicines, baby care, oral care, women’s health and wound care markets. The Pharmaceutical segment is focused on six therapeutic areas: Immunology, Infectious Diseases, Neuroscience, Oncology, Cardiovascular and Metabolism and Pulmonary Hypertension. The MedTech segment includes a range of products used in the interventional solutions, orthopaedics, surgery, and vision fields. Its geographic area includes the United States, Europe, Western Hemisphere (excluding the United States), and Africa, Asia and Pacific.

Johnson & Johnson Stock Underperforms Monday When Compared To Competitors Despite Daily Gains

4:32 pm ET November 21, 2022 (MarketWatch) Print

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Johnson & Johnson (JNJ) inched 0.51% higher to $175.97 Monday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index falling 0.39% to 3,949.94 and Dow Jones Industrial Average falling 0.13% to 33,700.28. The stock's fall snapped a five-day winning streak. Johnson & Johnson closed $10.72 short of its 52-week high ($186.69), which the company reached on April 25th.

The stock demonstrated a mixed performance when compared to some of its competitors Monday, as Roche Holding AG Part. Cert. rose 0.54% to $318.30, Merck & Co. Inc. (MRK) rose 1.32% to $105.61, and Pfizer Inc. (PFE) fell 0.10% to $48.18. Trading volume (5.4 M) remained 1.9 million below its 50-day average volume of 7.3 M.

Data source: Dow Jones Market Data, FactSet. Data compiled November 21, 2022.

(END) Dow Jones Newswires

November 21, 2022 16:32 ET (21:32 GMT)